Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.0 - $23.99 $0 - $37.3 Million
-1,555,000 Closed
0 $0
Q3 2023

Feb 14, 2024

BUY
$21.54 - $24.41 $33.5 Million - $38 Million
1,555,000 New
1,555,000 $35.2 Million
Q2 2023

Aug 14, 2023

BUY
$12.62 - $24.47 $3.79 Million - $7.34 Million
300,000 New
300,000 $7.34 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Taconic Capital Advisors LP Portfolio

Follow Taconic Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taconic Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Taconic Capital Advisors LP with notifications on news.